Register
Login:
Share:
Email Facebook Twitter


EXCLUSIVE: Aminex CEO says 'Institutions are delighted' with Zubair farm-out terms
EXCLUSIVE: InfraStrata continue to negotiate with major gas companies and institutional investors


Summit Ther Share Price (SUMM)



Share Price Information for Summit Ther (SUMM)


Share Price: 34.50Bid: 33.00Ask: 36.00Change: 0.00 (0.00%)No Movement on Summit Ther
Spread: 3.00Spread as %: 9.09%Open: 34.50High: 34.50Low: 34.50Yesterday’s Close: 34.50

Summit Therapeutics Plc Ord 1P

Summit Ther is listed in the FTSE AIM All-Share
Summit Ther is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
34.50
Share Price SpacerBid
33.00
Share Price SpacerAsk
36.00
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
149,250
Share Price SpacerOpen
34.50
Share Price SpacerHigh
34.50
Share Price SpacerLow
34.50
Share Price SpacerClose
34.50
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 81.99m £28.29m 1,500

52 Week High 265.00 52 Week High Date 11-SEP-2017
52 Week Low 32.50 52 Week Low Date 28-JUN-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
25 79,479 69,771 -3.136 -11.00 0.00 0.00


London South East Users info for Summit Ther




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

20-Jul-18
17:07:13
34.50
10,000
 
33.00
36.00
3,450
Trade Type:
Ordinary

20-Jul-18
16:17:02
35.80
2,220
Buy* 
33.00
36.00
794.76
Trade Type:
Ordinary

20-Jul-18
15:49:02
34.13
1,587
Sell* 
33.00
36.00
541.64
Trade Type:
Ordinary




View more Summit Ther trades >>

Directors Deals for Summit Ther (SUMM)
Trade DateActionNotifierPriceCurrencyAmountHolding
18-Jul-18Transfer From
Trade Notifier Information for Summit Therapeutics
Frank Armstrong held the position of Non-Executive Chairman at Summit Therapeutics at the time of this trade.
 Frank Armstrong
041,09680538
18-Jul-18Transfer From
Trade Notifier Information for Summit Therapeutics
Barry Price held the position of Non-Executive Director at Summit Therapeutics at the time of this trade.
 Barry Price
019,179116539
18-Jul-18Transfer From
Trade Notifier Information for Summit Therapeutics
Prof Stephen Davies held the position of Non-Executive Director at Summit Therapeutics at the time of this trade.
 Prof Stephen Davies
019,179621660
View more Summit Ther directors dealings >>


stew200
Posts: 10,363
Opinion:Strong Buy
Price:34.50
Great day ok the Nasdaq today
Today 22:31
Up nearly 8% surely that’s an open around 40p Monday
TrollHunter2
Posts: 188
Opinion:No Opinion
Price:34.50
RE: RNS
Thu 19:50
Unbelievable that troll is still preying on a company that was trying to help the young.
I've seen many trolls on many different share discussion boards and Pomander is the worst of all of them. Disgusting!
Chrisatrdg
Posts: 1,247
Opinion:Buy
Price:34.50
RE: Nasdaq
Thu 19:33
Hi dan1nat1 - I agree with you with regards NASDAQ for first time for a while NASDAQ is on the up.Fingers crossed.
dan1nat1
Posts: 452
Premium Chat Member
Opinion:No Opinion
Price:34.50
Nasdaq
Thu 18:38
Looking better on the NASDAQ so far today, hopefully the nudge we need to try to break 40p in the morning.
pomander
Posts: 5,490
Opinion:No Opinion
Price:36.00
RE: RNS
Thu 10:26
rotivatorman- I made my views on Mr Edwards very clear some time ago and copped it big time. His corporate strategy has never been in the best interests of shareholders. He has put himself first and spent his time travelling the world attending conferences and awarding himself share options.

Unfortunately, Mr Edwards has history -https://www.thepharmaletter.com/article/antisoma-ceo-and-finance-director-leave-after-pipeline-failures - shareholders were badly treated

I agree time for a change at the top - if you are on the cusp of a cure for DMD and C-Diff why even consider diverting resources to other minor drugs by comparison?
View more share chat for Summit Ther (SUMM) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.